Investment will include new sites in Memphis and Indianapolis
DHL Supply Chain is making further investments to strengthen its life sciences and healthcare capabilities in North America. The company announced that it has committed more than US$70.0 million to develop additional specialised warehousing infrastructure and deploy new technologies in support of its pharmaceutical and medical devices customers.
The latest commitment builds on the US$150.0 million investment that DHL Supply Chain announced in June 2019 to expand its US distribution network for the industry and bring critical healthcare products closer to trade partners and patients.
By making this investment, DHL is providing customers with a platform for further growth, as well as the flexibility they need to respond as essential services in a fast-changing environment.
DHL Supply Chain currently operates 30 specialised facilities with over 1.0 million m2 of temperature-controlled and certified infrastructure in the US. The new investment will include the development of new customer sites in Memphis, TN and Indianapolis, IN as well as the deployment of emerging technologies, such as the LocusBots collaborative robots that enhance picking productivity rates and site throughput. The Company announced plans earlier this year to increase its fleet of LocusBots to 1,000 by the end of this year.